Quantitative Concept
AstraZeneca Appeals IRA Loss, Reiterates Constitutional Challenge to Drug Price Negotiations
AstraZeneca, IRA, Medicare, Drug Price Negotiation, Constitutional Challenge, Appeal
FTC to Sue Major PBMs Over Insulin and Drug Prices Amid Anticompetitive Concerns
FTC, PBMs, Insulin Prices, Drug Prices, Anticompetitive Practices, Pharmacy Benefit Managers, Health Companies, Legal Action
Flagship’s Noubar Afeyan on Uncertainty, AI, and the Future of Biotechnology
, Noubar Afeyan, Flagship Pioneering, Biotechnology, Artificial Intelligence (AI), Uncertainty, Innovation, Future of Biotech, Moderna, Venture Capital,
How the world’s biggest pharma and biotech companies paid their typical worker in 2023
Midline (qualifier value), Wages, Pharma, Worker
How the world’s biggest pharma and biotech companies paid their typical worker in 2023
2023, Midline (qualifier value), Gilead, Wages, Average, Highest
Compensation Trends in the Pharmaceutical and Biotech Industry: 2023 Insights
pharmaceutical industry, biotech companies, median salary, employee pay, compensation trends, 2023
Biovance Capital Partners Launches with €51M to Boost Biotech in Southern Europe
Biovance Capital Partners, Biotech, Southern Europe, Venture Capital, Healthcare
SciRhom Secures €63 Million in Series A Funding for Autoimmune Therapies
SciRhom, autoimmune diseases, iRhom2, therapeutic strategy, Series A funding, biotech, pharmaceuticals
Myricx Bio Secures £90m ($114m) Series A Financing to Advance Novel NMTi ADC Therapeutics
Myricx Bio, Series A Financing, NMTi ADC Therapeutics, Novo Holdings, Lilly, Cancer Treatment
Myricx Secures $114M Funding with Lilly’s Support for ADC Development
Myricx, Eli Lilly, ADCs, Biotech Funding, Series A